It is a pharma private limited company based in Palakkad, Kerala, India, established in 2016.
2016 | Palakkad, Kerala, India | ActiveRenos Pharma Private Limited, a active private limited company, was established on 17 March 2016 in Palakkad, Kerala, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U51397KL2016PTC040395. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sunil Pai Dayananda (Director), Girishkumar Chandrasekarannair Mukkattu (Director), Jiji Chakkalakkal (Director). Past directors included Sunil Pai Dayananda, Girishkumar Chandrasekarannair Mukkattu, Prasanth Padinareveettil. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 21/555(8), Adithya Nagar, Nurani (P.O.), Palakkad, Kerala, 678004.
U51397KL2016PTC040395
040395
17 March 2016
₹1.00 M
₹0.10 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Renos Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunil Pai Dayananda | Director | 16 May 2016 | Current |
| Girishkumar Chandrasekarannair Mukkattu | Director | 16 May 2016 | Current |
| Jiji Chakkalakkal | Director | 17 Mar 2016 | Current |
| Prasanth Padinareveettil | Director | 16 May 2016 | Current |
| Sudheesh Unni Krishnan | Director | 16 May 2016 | Current |
| Anil Achuthannair | Managing Director | 17 Mar 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 29 Dec 2017 | Past |
| Pramod Abcsdd | Director | 29 Dec 2017 | Past |
| Pramod Abcsdd | Director | 29 Dec 2017 | Past |
| Pramod Abcsdd | Director | 29 Dec 2017 | Past |
| Pramod Abcsdd | Managing Director | 29 Dec 2017 | Past |
| Pramod Abcsdd | Director | 29 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Renos Pharma Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
In 2017, Renos Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Renos Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Renos Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renos Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Renos Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Renos Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was documented.
Progress on Sunil Pai Dayananda was appointed as a Director was appointed as a Director on 16 May 2016 & has been associated with this company since 9 years 7 months . was documented.
The activity Girishkumar Chandrasekarannair Mukkattu was appointed as a Director was appointed as a Director on 16 May 2016 & has been associated with this company since 9 years 7 months . was completed.
The activity Prasanth Padinareveettil was appointed as a Director was appointed as a Director on 16 May 2016 & has been associated with this company since 9 years 7 months . was completed.
Sudheesh Unni Krishnan was appointed as a Director was appointed as a Director on 16 May 2016 & has been associated with this company since 9 years 7 months . was recorded as a recent event.
The CIN of Renos Pharma Private Limited is U51397KL2016PTC040395.
Renos Pharma Private Limited is headquartered at 21/555(8), Adithya Nagar, Nurani (P.O.), Palakkad, Kerala, 678004.
Renos Pharma Private Limited was incorporated on 17 March 2016.
The current directors of Renos Pharma Private Limited are
The primary industry of Renos Pharma Private Limited is Pharma.
Renos Pharma Private Limited is unlisted.
The authorized capital of Renos Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Renos Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX